Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor alpha as a new therapeutic option
- PMID: 15361402
- PMCID: PMC1754753
- DOI: 10.1136/ard.2003.015743
Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor alpha as a new therapeutic option
Figures
Comment in
-
A costly therapeutic dilemma in tophaceous gout: is etanercept or rasburicase preferable?Ann Rheum Dis. 2005 Mar;64(3):516; author reply 516. Ann Rheum Dis. 2005. PMID: 15708917 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
